Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
How does the presence of 1-3 microbleeds on MRI influence your choice of anti-amyloid therapies for patients with MCI or mild AD?
Related Questions
How do you utilize FDG PET in the evaluation of dementias?
What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?
What is your approach to the management of transfusion reactions with lecanemab, both in the immediate setting and with respect to the prevention of reactions with future infusions?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
How do you differentiate between HIV associated neurocognitive disease (HAND) and other causes of neurocognitive impairment?
How do you treat agitation in progressive supranuclear palsy?
How do stroke-risk considerations affect your use of atypical antipsychotics for patients with dementia?
When do you suspect an autoimmune encephalitis in a child or adolescent with new-onset psychosis?
How do you counsel patients interested in carotid endarterectomy for asymptomatic carotid disease as a means to reduce dementia risk?
What would be your approach to the consideration of the use of antiamyloid monoclonal antibodies for nonamnestic Alzheimer's disease with a positive biomarker for brain amyloid pathology?
